Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies
A Jurcau, A Simion - International journal of molecular sciences, 2021 - mdpi.com
Its increasing incidence has led stroke to be the second leading cause of death worldwide.
Despite significant advances in recanalization strategies, patients are still at risk for …
Despite significant advances in recanalization strategies, patients are still at risk for …
Role of neuroinflammation in neurodegeneration development
Studies in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease
and Amyotrophic lateral sclerosis, Huntington's disease, and so on, have suggested that …
and Amyotrophic lateral sclerosis, Huntington's disease, and so on, have suggested that …
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Neurotransmitters serve as chemical messengers playing a crucial role in information
processing throughout the nervous system, and are essential for healthy physiological and …
processing throughout the nervous system, and are essential for healthy physiological and …
Insights into the pathogenesis of neurodegenerative diseases: Focus on mitochondrial dysfunction and oxidative stress
A Jurcau - International Journal of Molecular Sciences, 2021 - mdpi.com
As the population ages, the incidence of neurodegenerative diseases is increasing. Due to
intensive research, important steps in the elucidation of pathogenetic cascades have been …
intensive research, important steps in the elucidation of pathogenetic cascades have been …
[HTML][HTML] Molecular mechanisms of ischemia and glutamate excitotoxicity
Excitotoxicity is classically defined as the neuronal damage caused by the excessive
release of glutamate, and subsequent activation of excitatory plasma membrane receptors …
release of glutamate, and subsequent activation of excitatory plasma membrane receptors …
[HTML][HTML] Mesenchymal stem cells in treatment of spinal cord injury and amyotrophic lateral sclerosis
E Sykova, D Cizkova, S Kubinova - Frontiers in cell and …, 2021 - frontiersin.org
Preclinical and clinical studies with various stem cells, their secretomes, and extracellular
vesicles (EVs) indicate their use as a promising strategy for the treatment of various …
vesicles (EVs) indicate their use as a promising strategy for the treatment of various …
[HTML][HTML] Masitinib: The promising actor in the next season of the amyotrophic lateral sclerosis treatment series
Abstract Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease with high
mortality and morbidity rate affecting both upper and lower motor neurons (MN). Muscle …
mortality and morbidity rate affecting both upper and lower motor neurons (MN). Muscle …
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
A Adamu, S Li, F Gao, G Xue - Frontiers in Aging Neuroscience, 2024 - frontiersin.org
Neuroinflammation refers to a highly complicated reaction of the central nervous system
(CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a …
(CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a …
The sense of antisense therapies in ALS
SH Van Daele, P Masrori, P Van Damme… - Trends in Molecular …, 2024 - cell.com
Abstract Treatment of patients with amyotrophic lateral sclerosis (ALS) has entered a new
era now that encouraging results about antisense oligonucleotides (ASOs) are becoming …
era now that encouraging results about antisense oligonucleotides (ASOs) are becoming …
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with motor neuron loss
as a defining feature. Despite significant effort, therapeutic breakthroughs have been …
as a defining feature. Despite significant effort, therapeutic breakthroughs have been …